NCT00669344 - RIVastigmine In Vascular cognitivE Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

February 29, 2008

Conditions

Cognitive Impairment

Interventions

DRUG

Exelon (rivastigmine)

Capsules, twice daily orally. Dosage starts at 1.5mg bis diem to 4.5mg bis diem.

DRUG

Placebo

Capsule, twice daily orally. Dosage starts at 1.5mg bis diem to 4.5mg bis diem.

Trial Locations (1)

Singapore General Hospital, Singapore